Finance

Beta
Lists
688266:SHA
Suzhou Zelgen Biopharmaceuticals Co Ltd
CN¥87.70
-3.05%
(-2.76) 1D
Jun 17, 11:29:43 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688266...
Open
CN¥89.00
High
CN¥90.00
Low
CN¥87.40
Mkt. cap
23.87B
Avg. vol.
3.97M
Volume
1.59M
P/E ratio
46.62
52-wk high
CN¥134.17
52-wk low
CN¥75.10
EPS
CN¥1.88
No. of employees
1K
Open
CN¥89.00
High
CN¥90.00
Low
CN¥87.40
Mkt. cap
23.87B
Avg. vol.
3.97M
Volume
1.59M
P/E ratio
46.62
52-wk high
CN¥134.17
52-wk low
CN¥75.10
EPS
CN¥1.88
No. of employees
1K
News stories
From sources across the web
About Suzhou Zelgen Biopharmaceuticals Co Ltd
CEO-
Employees1.06K
FoundedMar 18, 2009
Headquarters-
SectorBiotechnology
Websitezelgen.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
208.01M
217.79M
217.04M
905.39M
Cost of goods sold
22.94M
14.54M
25.03M
27.04M
Cost of revenue
22.94M
14.54M
25.03M
27.04M
Research and development expenses
94.27M
106.28M
127.13M
92.28M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
140.58M
128.56M
160.34M
151.23M
Operating expense
259.17M
208.28M
315.51M
247.77M
Total operating expenses
282.10M
222.82M
340.53M
274.81M
Operating income
-74.09M
-5.03M
-123.49M
630.58M
Other non operating income
-117.64K
-96.86K
279.05K
-6.83M
EBT including unusual items
-47.10M
-20.90M
-70.34M
631.77M
EBT excluding unusual items
-66.45M
5.30M
-118.30M
631.73M
Income tax expense
-841.38K
-877.77K
-805.16K
-841.97K
Effective tax rate
1.79%
4.20%
1.14%
-0.13%
Other operating expenses
22.35M
-26.77M
29.52M
2.33M
Net income
-44.54M
-20.61M
-69.53M
632.61M
Net profit margin
-21.41%
-9.46%
-32.03%
69.87%
Earnings per share
-
-
-
-
Interest and investment income
14.47M
13.73M
12.79M
13.97M
Interest expense
-6.67M
-3.35M
-6.97M
-6.00M
Net interest expenses
7.81M
10.38M
5.82M
7.98M
Depreciation and amortization charges
-
-
-
-
EBITDA
-63.45M
5.70M
-113.00M
641.07M
Gain or loss from assets sale
-810.00
810.00
-810.00
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more